-
市场
-
产品
-
资讯
-
Moo社区
-
课堂
-
查看更多
-
功能介绍
-
费用费用透明,无最低余额限制
投资选择、功能介绍、费用相关信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 浅色
Short Interest in Cellebrite DI Ltd. (NASDAQ:CLBT) Expands By 12.3%
Short Interest in Cellebrite DI Ltd. (NASDAQ:CLBT) Expands By 12.3%
Cellebrite DI Ltd. (NASDAQ:CLBT – Get Rating) was the target of a significant growth in short interest during the month of August. As of August 31st, there was short interest totalling 1,730,000 shares, a growth of 12.3% from the August 15th total of 1,540,000 shares. Currently, 4.8% of the shares of the company are sold short. Based on an average trading volume of 126,600 shares, the short-interest ratio is currently 13.7 days.
Institutional Investors Weigh In On Cellebrite DI
Several hedge funds and other institutional investors have recently modified their holdings of CLBT. Blair William & Co. IL acquired a new stake in shares of Cellebrite DI in the fourth quarter worth $135,000. Diametric Capital LP bought a new position in Cellebrite DI in the fourth quarter worth $209,000. ETF Managers Group LLC bought a new position in Cellebrite DI in the fourth quarter worth $462,000. Greenhaven Road Investment Management L.P. bought a new position in Cellebrite DI in the fourth quarter worth $9,453,000. Finally, Yarbrough Capital LLC bought a new position in Cellebrite DI in the first quarter worth $414,000. Institutional investors and hedge funds own 20.41% of the company's stock.
Get Cellebrite DI alerts:Analyst Upgrades and Downgrades
A number of brokerages recently issued reports on CLBT. Needham & Company LLC increased their target price on shares of Cellebrite DI from $6.00 to $6.50 and gave the company a "buy" rating in a research report on Thursday, August 11th. Cowen reduced their price objective on shares of Cellebrite DI from $13.00 to $10.00 and set an "outperform" rating for the company in a research report on Friday, August 12th. Bank of America lowered shares of Cellebrite DI from a "buy" rating to a "neutral" rating and reduced their price objective for the company from $6.50 to $6.00 in a research note on Friday, August 12th. Cowen reduced their price objective on shares of Cellebrite DI from $13.00 to $10.00 and set an "outperform" rating for the company in a research note on Friday, August 12th. Finally, William Blair lowered shares of Cellebrite DI from an "outperform" rating to a "market perform" rating in a research report on Friday, August 12th. Two equities research analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. According to MarketBeat, the company has a consensus rating of "Moderate Buy" and an average target price of $9.71.
Cellebrite DI Stock Down 1.8 %
Shares of CLBT stock opened at $4.21 on Wednesday. Cellebrite DI has a 12 month low of $4.10 and a 12 month high of $11.60. The business's 50 day moving average is $5.07 and its two-hundred day moving average is $5.36. The company has a market cap of $793.75 million, a PE ratio of 5.69, a price-to-earnings-growth ratio of 10.14 and a beta of 0.87.Cellebrite DI Company Profile
(Get Rating)
Cellebrite DI Ltd. develops solutions for legally sanctioned investigations. Its DI platform allows users to collect, review, analyze, and manage digital data across the investigative lifecycle with respect to legally sanctioned investigations and solutions are used in a various case, including child exploitation, homicide, anti-terror, border control, sexual crimes, human trafficking, corporate security, intellectual property theft, and civil litigation.
Read More
- Get a free copy of the StockNews.com research report on Cellebrite DI (CLBT)
- 3 Airline Stocks Stuck in a Holding Pattern
- Roku Stock is Down but Not Out
- If You're Hungry for Value, Take a Bite on Ruth's Hospitality Grp
- Is Ford Rolling To A Rebound After Its Q3 Warning
- Has AMD stock stock fallen too far?
Receive News & Ratings for Cellebrite DI Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cellebrite DI and related companies with MarketBeat.com's FREE daily email newsletter.
Cellebrite DI Ltd. (NASDAQ:CLBT – Get Rating) was the target of a significant growth in short interest during the month of August. As of August 31st, there was short interest totalling 1,730,000 shares, a growth of 12.3% from the August 15th total of 1,540,000 shares. Currently, 4.8% of the shares of the company are sold short. Based on an average trading volume of 126,600 shares, the short-interest ratio is currently 13.7 days.
凯莱布里特DI有限公司(纳斯达克代码:CLBT-GET评级)是空头股数在8月份实现显著增长的目标。截至8月31日,空头股数共有1,730,000股,较8月15日的1,540,000股增长12.3%。目前,该公司4.8%的股份被卖空。以12.66万股的平均成交量计算,目前短息比率为13.7天。
Institutional Investors Weigh In On Cellebrite DI
机构投资者看好Cellebrite DI
Several hedge funds and other institutional investors have recently modified their holdings of CLBT. Blair William & Co. IL acquired a new stake in shares of Cellebrite DI in the fourth quarter worth $135,000. Diametric Capital LP bought a new position in Cellebrite DI in the fourth quarter worth $209,000. ETF Managers Group LLC bought a new position in Cellebrite DI in the fourth quarter worth $462,000. Greenhaven Road Investment Management L.P. bought a new position in Cellebrite DI in the fourth quarter worth $9,453,000. Finally, Yarbrough Capital LLC bought a new position in Cellebrite DI in the first quarter worth $414,000. Institutional investors and hedge funds own 20.41% of the company's stock.
几家对冲基金和其他机构投资者最近调整了对CLBT的持股。Blair William&Co.IL在第四季度收购了价值13.5万美元的Cellebrite DI新股。Diameter Capital LP在第四季度购买了Cellebrite DI的一个新头寸,价值20.9万美元。ETF Manager Group LLC在第四季度购买了Cellebrite DI的新头寸,价值46.2万美元。Greenaven Road Investment Management L.P.在第四季度购买了Cellebrite DI的一个新头寸,价值9,453,000美元。最后,Yarbough Capital LLC在第一季度购买了Cellebrite DI的一个新头寸,价值41.4万美元。机构投资者和对冲基金持有该公司20.41%的股票。
Analyst Upgrades and Downgrades
分析师升级和下调评级
A number of brokerages recently issued reports on CLBT. Needham & Company LLC increased their target price on shares of Cellebrite DI from $6.00 to $6.50 and gave the company a "buy" rating in a research report on Thursday, August 11th. Cowen reduced their price objective on shares of Cellebrite DI from $13.00 to $10.00 and set an "outperform" rating for the company in a research report on Friday, August 12th. Bank of America lowered shares of Cellebrite DI from a "buy" rating to a "neutral" rating and reduced their price objective for the company from $6.50 to $6.00 in a research note on Friday, August 12th. Cowen reduced their price objective on shares of Cellebrite DI from $13.00 to $10.00 and set an "outperform" rating for the company in a research note on Friday, August 12th. Finally, William Blair lowered shares of Cellebrite DI from an "outperform" rating to a "market perform" rating in a research report on Friday, August 12th. Two equities research analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. According to MarketBeat, the company has a consensus rating of "Moderate Buy" and an average target price of $9.71.
多家券商近日发布了关于CLBT的报告。Needham&Company LLC在8月11日星期四的一份研究报告中将Cellebrite DI的目标价从6.00美元上调至6.50美元,并给予该公司“买入”评级。考恩在8月12日星期五的一份研究报告中将Cellebrite DI的股票目标价从13.00美元下调至10.00美元,并为该公司设定了“跑赢大盘”的评级。在8月12日星期五的一份研究报告中,美国银行将Cellebrite DI的股票评级从买入下调至中性,并将该公司的目标价从6.50美元下调至6.00美元。考恩在8月12日星期五的一份研究报告中将Cellebrite DI的股票目标价从13.00美元下调至10.00美元,并为该公司设定了“跑赢大盘”的评级。最后,在8月12日星期五的一份研究报告中,威廉·布莱尔将Cellebrite DI的股票评级从“跑赢大盘”下调至“市场表现”。两名股票研究分析师对该股的评级为持有,六名分析师对该公司的评级为买入。根据MarketBeat的数据,该公司的普遍评级为“适度买入”,平均目标价为9.71美元。
Cellebrite DI Stock Down 1.8 %
Cellebrite DI股价下跌1.8%
Cellebrite DI Company Profile
Cellebrite DI公司简介
(Get Rating)
(获取评级)
Cellebrite DI Ltd. develops solutions for legally sanctioned investigations. Its DI platform allows users to collect, review, analyze, and manage digital data across the investigative lifecycle with respect to legally sanctioned investigations and solutions are used in a various case, including child exploitation, homicide, anti-terror, border control, sexual crimes, human trafficking, corporate security, intellectual property theft, and civil litigation.
Cellebrite DI Ltd.为法律批准的调查开发解决方案。其DI平台允许用户在整个调查生命周期中收集、审查、分析和管理与法律批准的调查有关的数字数据,并在各种案件中使用解决方案,包括剥削儿童、凶杀、反恐、边境控制、性犯罪、人口贩运、企业安全、知识产权盗窃和民事诉讼。
Read More
阅读更多内容
- Get a free copy of the StockNews.com research report on Cellebrite DI (CLBT)
- 3 Airline Stocks Stuck in a Holding Pattern
- Roku Stock is Down but Not Out
- If You're Hungry for Value, Take a Bite on Ruth's Hospitality Grp
- Is Ford Rolling To A Rebound After Its Q3 Warning
- Has AMD stock stock fallen too far?
- 免费获取StockNews.com关于Cellebrite DI(CLBT)的研究报告
- 3家航空公司股票陷入持有格局
- Roku股票下跌,但并未出局
- 如果你渴望价值,那就尝尝露丝的好客之道吧
- 福特在第三季度发出警告后是否正在反弹
- AMD股票是不是跌得太厉害了?
Receive News & Ratings for Cellebrite DI Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cellebrite DI and related companies with MarketBeat.com's FREE daily email newsletter.
接受《凯尔布赖特DI日报》的新闻和评级-在下面输入您的电子邮件地址,通过MarketBeat.com的免费每日电子邮件时事通讯接收对Cellebrite DI和相关公司的最新新闻和分析师评级的每日简要摘要。
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
风险及免责提示
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用浏览器的分享功能,分享给你的好友吧